Q2 FY2026 · ended Jun 30, 2026 · Revenue $87.83M, +43.1% YoY · Filed Aug 7, 2026
Omada Health, Inc. (OMDA) files with the SEC under industry code 8000, Services-Health Services. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $87.8 million and net income of $5.3 million. Free cash flow was $3.9 million.
Revenue
$87.83M
+43.1% vs year-ago quarter
Net income
$5.29M
+199.7% vs year-ago quarter
Operating cash flow
$4.01M
+130.2% vs year-ago quarter
Free cash flow
$3.86M
+127.9% vs year-ago quarter
EPS
$0.08
+133.3% vs year-ago quarter
Dividend per share
None
Shares outstanding
61.22M
+6.3% vs year-ago quarter
Net cash
$222.04M
Q4 FY2025
Operating margin
-0.1%
TTM
Company profile
- Industry
- Services-Health Services (SIC 8000)
- Listed as
- OMDA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1611115
Other Services-Health Services companies
- LifeStance Health Group, Inc. LFST
- Privia Health Group, Inc. PRVA
- GeneDx Holdings Corp. WGS
- Pennant Group, Inc. PNTG
- U S Physical Therapy Inc /NV USPH
- InnovAge Holding Corp. INNV
- P3 Health Partners Inc. PIII
- Alps Group Inc ALPS
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q2 FY2026 Jun 30, 2026 |
Q1 FY2026 Mar 31, 2026 |
Q4 FY2025 Dec 31, 2025 |
Q3 FY2025 Sep 30, 2025 |
Q2 FY2025 Jun 30, 2025 |
|---|---|---|---|---|---|
| Revenue | $87.8M | $78.0M | $75.8M | $68.0M | $61.4M |
| Operating income | $3.5M | -$4.8M | $3.3M | -$2.5M | -$4.3M |
| Net income | $5.3M | -$3.0M | $5.2M | -$3.2M | -$5.3M |
| Diluted EPS | $0.08 | -$0.05 | $0.09 | -$0.06 | -$0.24 |
| Operating cash flow | $4.0M | -$11.8M | $21.4M | $10.1M | -$13.3M |
| Free cash flow | $3.9M | -$11.9M | $21.2M | $9.6M | -$13.8M |
| Total assets | $328.2M | $302.8M | $305.4M | $287.5M | $303.0M |
| Total liabilities | $75.5M | $68.7M | $75.7M | $70.1M | $88.8M |
| Stockholders' equity | $252.7M | $234.1M | $229.7M | $217.3M | $214.2M |
| Cash and investments | $221.7M | $211.8M | $222.0M | $198.6M | $223.1M |
| Total debt | — | — | $0 | $0 | $30.0M |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 7, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 16, 2026 | Jun 16, 2026 |
| 10-Q | Quarterly report | May 8, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 7, 2026 | May 7, 2026 |
All 237 Omada Health, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.